ANT-INTERNATIONAL
On 2024 International MSME Day, Ant International, a digital payment and financial services leader, shares that it supports almost 100 million Micro, Small, and Medium-sized Enterprises (MSMEs) worldwide across its businesses and partner programs; and reinforces its commitments towards MSME digitalization and inclusion through the expansion of its services, new programs for skills development with industry partners, and a new global campaign.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240626356788/en/
(Photo: Business Wire)
“MSMEs are the lifeblood of our economies, driving innovation, employment, and inclusive development,” said Douglas Feagin, President of Ant International. “Their resilience and entrepreneurial spirit deserve to be celebrated and nurtured. At Ant International, we firmly believe in the power of small and that small businesses can make a big impact. Fintech innovations today unlock new possibilities for small businesses to dream boldly and compete globally. Together with our partners, we want to ensure that every business and every person will have access to the knowledge, network, and digital tools to help them achieve their goals.”
Empowering growth for MSMEs through digitalization
Across its businesses, Ant International offers solutions that enable MSMEs to digitalize, opening new growth opportunities.
Alipay+, the cross-border mobile payments and marketing solutions operated by Ant International, announced an expansion of its global acceptance. As of June 2024, Alipay+ is accepted by over 90 million merchants in over 66 markets, connecting businesses to users of 30 international payment partners. With travel picking up and tourism a key driver of many local economies, this enables many small businesses to connect with global mobile-first consumers in a simple, cost-efficient manner.
A key development in driving digitalization at scale is through Alipay+’s integration with national QRs. Alipay+ is currently integrated with the national QRs of Singapore, Malaysia and South Korea, which counts MSMEs as majority of its merchants. In Singapore, Alipay+ transactions at hawker stalls have increased 52% in H1 2024, compared to H2 2023. In Malaysia and South Korea, Alipay+ transactions increased 44% and 54% respectively via PayNet and ZeroPay, in Q2 vs Q1 2024. Alipay+ also has partnerships with national QRs in Cambodia, Nepal and Sri Lanka.
As a leading provider of digital payment solutions, Antom supports merchants of all sizes, including MSMEs, across over 40 countries and regions. Through a single integration, Antom connects them to more than 250 payment methods in over 150 markets. Its D-store solution enables MSME merchants to digitalize their operations and set up an online store in just 10 minutes with zero upfront cost. Over 5000 outlets have already onboarded this solution, with average monthly transactions growing by 27% in Q2 vs Q1 2024.
In supporting MSMEs to do business globally, WorldFirst empowers more than 1 million SMEs with international payments to 200+ markets in over 100 currencies. To enable more SMEs to do cross-border trade, WorldFirst will expand to more markets in Southeast Asia and Europe this year. ANEXT Bank, a digital wholesale bank incorporated in Singapore, recently celebrated its second anniversary, with two times year-on-year increase in its customer base, of which 69% are micro businesses. To further support regional MSMEs, ANEXT Bank has introduced its second batch of SME Friends of ANEXT with forward-thinking small and growing businesses to co-create the “digital bank of tomorrow”.
Ant International has also recently unveiled bettr, a new global digital lending service to provide micro lending to MSMEs through embedded finance partnerships, further accelerating financial inclusion.
Harnessing industry partnerships to drive MSME development
Ant International believes in open industry collaboration to jointly support knowledge and skills development for MSMEs.
In Indonesia, Ant International and DANA will launch the second edition of SisBerdaya, an initiative that provides female micro entrepreneurs training, mentoring, and educational programs in business management and digital skills. Started in 2023, the first edition drew more than 2700 applicants, with 180 participants undergoing a one-month training, and grants awarded to 30 entrepreneurs.
In collaboration with the International Finance Corporation, 10x1000 Tech for Inclusion is an open learning platform to help future digital leaders develop more skills to drive greater impact within their communities. As of 2023, with the support of 40+ global strategic partners, more than 6,000 individual talents from 100+ countries and regions completed the 10x1000 learning programs, of which 90% are from developing markets and 60% work in MSMEs.
Earlier this year, Ant International launched Programme Sirius, with the support of 13 Asia Pacific fintech leaders to empower MSMEs in their transition towards sustainability, in line with the United Nationals Sustainable Development Goals.
Global campaign to ‘Embrace the power of small’
In celebration of International MSME Day, Ant International launches its “Embrace the power of small” campaign featuring three business owners and their journeys of digitalization. The business owners are:
Cholthicha Joyyangsuk (Numwan), Thailand – a micro entrepreneur in Bangkok selling Thai desserts on her tuktuk. With Alipay+, she can now easily accept mobile payments from tourists, sharing a slice of culture, while giving her access to a wider pool of customers.
Lem Cheong, The Hainan Story, Singapore – inspired by his grandma’s rich heritage and flavourful recipes, Mr Cheong aims to evolves traditional dishes, just as he evolves his business with digital tools like Antom’s D-store solution to simplify his store operations.
Lewis Ames, Wrimes Cosmetics, UK – starting with neon face paint and pivoting to pet care during the pandemic, Mr Ames uses WorldFirst to pay his suppliers and collect payments from marketplaces easily, so he can grow his business from Stevenage to the world.
These stories will be featured on out-of-home billboards, starting in Europe, in time for the UEFA EURO 2024, of which Ant International is the Official Payment Partner, and rolled out to other global markets, and also on TV and social media.
About Ant International
Headquartered in Singapore, Ant International powers the future of global commerce with digital innovation for everyone and every business to thrive. In close collaboration with partners, we support merchants of all sizes worldwide to realize their growth aspirations through a comprehensive range of tech-driven digital payment and financial services solutions.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240626356788/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Takeda’s Zasocitinib Landmark Phase 3 Plaque Psoriasis Data Show Promise to Deliver Clear Skin in a Once-Daily Pill, Catalyzing a New Era of Treatment18.12.2025 09:00:00 CET | Press release
Pivotal Phase 3 studies of once-daily oral zasocitinib met all primary and ranked secondary endpoints in patients with moderate-to-severe plaque psoriasis More than half of study participants treated with zasocitinib achieved clear or almost clear skin (PASI 90), and on average about 30 percent achieved completely clear skin (PASI 100) by week 16 Zasocitinib was generally well-tolerated with a safety profile consistent with previous clinical studies Takeda(TSE:4502/NYSE:TAK)today announced positive topline results for the two pivotal Phase 3randomized, multicenter, double-blind, placebo- and active comparator-controlled studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO). The studies demonstrated superiority of zasocitinib compared to placebo for the co-primary endpoints, static Physician Global Assessment (sPGA) 0/1 and Psoriasis Area and Severity Index (PASI) 75, at wee
DATROWAY® Type II Variation Application Validated in the EU as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who are Not Candidates for Immunotherapy18.12.2025 08:30:00 CET | Press release
Based on TROPION-Breast02 phase 3 trial results where Daiichi Sankyo and AstraZeneca’s DATROWAY is the first and only medicine to significantly improve overall survival versus chemotherapy in this patient population If approved, DATROWAY could become the standard of care in this setting The European Medicines Agency (EMA) has validated the Type II Variation marketing authorization application for DATROWAY® (datopotamab deruxtecan) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. DATROWAY is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/Nasdaq: AZN). The validation confirms the completion of the application and commences the scientific review process by the EMA’s Committee for Medicinal Produc
Celltrion receives positive CHMP Opinion for SteQeyma™ (ustekinumab biosimilar) autoinjector18.12.2025 03:41:00 CET | Press release
SteQeyma™45mg and 90mg solution for injection via autoinjector (pre-filled pen) receives positive CHMP opinion, which will facilitate subcutaneous administration in patients with plaque psoriasis, psoriatic arthritis (PsA) and Crohn’s disease (CD)1The new autoinjector option increases convenience, enhances individual patient experience and expands administration options Celltrion, Inc. today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion of autoinjector of SteQeyma™, a biosimilar to Stelara® (ustekinumab), for the treatment of plaque psoriasis, psoriatic arthritis (PsA) and Crohn’s disease (CD). The positive CHMP opinion is for SteQeyma autoinjector in 45mg/0.5mL and 90mg/1mL, expanding the currently approved SteQeyma™ presentation, which includes 45mg/0.5mL, 90mg/1mL in a pre-filled syringe and 45mg/0.5mL in a vial for subcutaneous injection, as well as 130mg/26mL concentrate for solution f
Megaport Expands into India, Accelerating Global Growth with Extreme IX Acquisition18.12.2025 02:15:00 CET | Press release
Through the Extreme Exchange (IX) acquisition, Megaport gains seven Internet Exchanges and access to 40+ data centres across India’s fastest-growing digital hubs. Megaport Limited (ASX: MP1) (“Megaport”), the world’s leading Network as a Service (NaaS) provider, today announced the acquisition of Extreme IX,India’s leading Internet Exchange operator, from Extreme Labs, a Bulgaria-headquartered software and network engineering company that incubated the Extreme IX platform. The acquisition expands Megaport’s global platform into one of the world’s fastest-growing digital infrastructure markets and supports the Company’s strategy to deliver scalable, high-performance connectivity services across APAC. The acquisition establishes Megaport’s presence across seven Internet Exchanges in major Indian metros: Delhi, Kolkata, Hyderabad, Chennai, Bengaluru, Mumbai, and Pune, connecting 40+ data centres and more than 400 customers. It also accelerates Megaport’s planned market entry by nearly thr
IonQ and QuantumBasel Expand Long-Term Partnership in Next-Generation Quantum Systems17.12.2025 22:10:00 CET | Press release
Extension solidifies QuantumBasel as IonQ’s Innovation Center in Europe; adds IonQ Tempo and next-generation system to advance quantum commercialization IonQ (NYSE: IONQ), the world’s leading quantum company, today announced an expanded agreement with QuantumBasel, the quantum initiative of uptownBasel, Switzerland’s innovation campus. The extended contract grants QuantumBasel ownership of its existing IonQ Forte Enterprise system and secures ownership of a next-generation Tempo system. This new agreement brings the total deal value of the QuantumBasel and IonQ partnership to over $60 million and extends IonQ’s on-site presence in Switzerland four more years, continuing through 2029. QuantumBasel is IonQ’s official Innovation Center in Europe, serving as a hub for European industry, academia, and research institutions to explore practical quantum computing applications and access IonQ’s latest enterprise-grade systems. “Our extended partnership with QuantumBasel represents a cornerston
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom